[1. Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis. 2009; 53: S4-16.10.1053/j.ajkd.2008.07.048]Search in Google Scholar
[2. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39: S1-266.]Search in Google Scholar
[3. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008; 8: 117.10.1186/1471-2458-8-117]Search in Google Scholar
[4. Tonelli M, Riella M. Chronic kidney disease and the ageing population. Lancet. 2014; 383: 1278-1279.10.1016/S0140-6736(14)60155-0]Search in Google Scholar
[5. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013; 382: 339-352.10.1016/S0140-6736(13)60595-4]Search in Google Scholar
[6. Grams ME, Juraschek SP, Selvin E et al. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates. Am J Kidney Dis. 2013; 62: 253-260.10.1053/j.ajkd.2013.03.013]Search in Google Scholar
[7. Zoccali C. Cardiorenal risk as a new frontier of nephrology: research needs and areas for intervention. Nephrol Dial Transplant. 2002; 17 Suppl 11: 50-54.10.1093/ndt/17.suppl_11.50]Search in Google Scholar
[8. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-3421.10.1161/circ.106.25.3143]Search in Google Scholar
[9. Tonelli M, Muntner P, Lloyd A et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012; 380: 807-814.10.1016/S0140-6736(12)60572-8]Search in Google Scholar
[10. Stone NJ, Robinson JG, Lichtenstein AH et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: S1-45.]Search in Google Scholar
[11. Grams ME, Chow EK, Segev DL, Coresh J. Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis. 2013; 62: 245-252.10.1053/j.ajkd.2013.03.009372371123566637]Search in Google Scholar
[12. Hoerger TJ, Wittenborn JS, Segel JE et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010; 55: 463-473.10.1053/j.ajkd.2009.11.01720116910]Search in Google Scholar
[13. Fink HA, Ishani A, Taylor BC et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012; 156: 570-581.10.7326/0003-4819-156-8-201204170-0000822508735]Search in Google Scholar
[14. Qaseem A, Hopkins RH, Jr., Sweet DE et al. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013; 159: 835-847.10.7326/0003-4819-159-11-201312030-0000924297193]Search in Google Scholar
[15. Hill NR, Lasserson D, Fatoba S et al. The Oxford Renal (OxRen) cross-sectional study of chronic kidney disease in the UK. BMJ Open. 2013; 3: e004265.10.1136/bmjopen-2013-004265388462424345903]Search in Google Scholar
[16. Meisinger C, Doring A, Lowel H. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population. Eur Heart J. 2006; 27: 1245-1250.10.1093/eurheartj/ehi88016611670]Search in Google Scholar
[17. Reinhold T, Lindig C, Willich SN, Bruggenjurgen B. The costs of myocardial infarction - a longitudinal analysis using data from a large German health insurance company. J Public Health 19, 579-586. 2011.10.1007/s10389-011-0420-8]Search in Google Scholar
[18. Icks A, Haastert B, Gandjour A et al. Costs of dialysis-- a regional population-based analysis. Nephrol Dial Transplant. 2010; 25: 1647-1652.10.1093/ndt/gfp67220008830]Search in Google Scholar
[19.http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/File:Gross_domestic_product_at_market_prices_2011.png. Eurostat. 2014.]Search in Google Scholar